Role of restenosis in determining adverse outcome after coronary angioplasty vs bypass surgery
- 4 Downloads
A group of patients who did not have restenosis after percutaneous transluminal coronary angioplasty (PTCA) was compared with a group receiving coronary artery bypass grafting (CABG). Restenosis only partially accounted for the greater morbidity after PTCA compared with CABG.
Unable to display preview. Download preview PDF.
- 2.Lau K-W, Sigwart U. Restenosis after PTCA: risk factors and pathophysiology.J Myocardial Ischemia. 1992;4:15–33.Google Scholar
- 4.The EPIC investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty.N Engl J Med. 1994;330:1031–1037.Google Scholar
- 5.Kurbaan AS, Sigwart U. Coronary stenting: past, present, and future. In: Feuerstein G, ed.Coronary Restenosis: From Genetics to Therapeutics. New York, NY: Marcel Dekker Inc; 1996.Google Scholar
- 7.Gershlick A, Brack MJ, More RS, Syndercombe-Court D, Balcon R. Angiographic restenosis after angioplasty: comparison of definitions and correlation with clinical outcome.Coronary Artery Dis. 1993;4:73–81.Google Scholar
- 12.MERCATOR Study Group. Does the new angiotensin-converting enzyme inhibitor cilazapril prevent restenosis after percutaneous coronary angioplasty?Circulation. 1992;86:100–110.Google Scholar
- 13.Hillegrass WB, Ohman EM, Califf RM. Restenosis: the clinical issues: In: Topol EJ, ed.Textbook of Interventional Cardiology. Philadelphia, Pa: WB Saunders Co; 1994:415–435.Google Scholar
- 18.CASS Group. The Coronary Artery Surgery Study (CASS): a randomised trial of coronary artery bypass surgery: survival data.Circulation. 1983;68:939–950.Google Scholar